| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0094 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |